Organon & Co (OGN)
Healthcare
Drug Manufacturers - General
13.60 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -225 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 261 | 397 | 76 | 332 | 141 | 390 | 75 | 220 | 264 | 141 | 225 | -225 | 405 | |
| 61 | 60 | 65 | 66 | 69 | 77 | 84 | 89 | 92 | 240 | 86 | -86 | 332 | |
| 27 | 27 | 26 | 28 | 25 | 26 | 24 | 22 | 24 | 7.0 | 19 | -19 | 31 | |
| 52 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 90 | 225 | -223 | -301 | -167 | 112 | -125 | -61 | -27 | -34 | 42 | -42 | -61 | |
| 55 | 81 | 96 | 32 | 76 | 132 | 97 | 39 | 115 | 45 | 37 | 37 | 234 | |
| -179 | -81 | -96 | -46 | -75 | -296 | -172 | -38 | -115 | -65 | 386 | -386 | -180 | |
| 74 | 73 | 70 | 79 | 74 | 74 | 71 | 10 | 3.0 | 4.0 | 5.0 | 5.0 | 17 | |
| -2.0 | -2.0 | -2.0 | -14 | -2.0 | -4.0 | -1.0 | -12 | -1.0 | – | – | – | – | |
| -2.0 | – | – | – | -2.0 | -2.0 | -3.0 | -201 | -72 | -182 | -32 | 0.0 | -286 | |
| -78 | -77 | -74 | -134 | -78 | -82 | -75 | -223 | -76 | -187 | -38 | 38 | -263 | |
| 88 | 279 | -118 | 129 | 59 | -88 | -128 | 52 | 73 | -98 | 542 | -1,115 | -598 | |
| 206 | 316 | -20 | 300 | 65 | 258 | -22 | 181 | 149 | 96 | 188 | -188 | 245 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.